Status:
RECRUITING
HyperSpectral Imaging in Low Grade Glioma
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Collaborating Sponsors:
Imec
Carl Zeiss Meditec AG
Conditions:
Low Grade Glioma of Brain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Low grade glioma (LGG) is a slowly evolving, highly invasive intrinsic brain tumor displaying only subtle tissue differences with the normal surrounding brain, hampering the attempts to visually discr...
Detailed Description
Included patients will undergo a resection of the low grade glioma as standard-of-care. Before, during and after the resection, HSI data ('datacubes') will be acquired by the SnapScan HSI camera on th...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Radiologically suspected low grade glioma (newly diagnosed or recurrent)
- Scheduled for tumor resection at UZ Leuven
- Signed informed consent document prior to resection
Exclusion
- Children with age \< 18 years
- If final pathology reveals other pathological diagnosis than low grade glioma, datacubes will not be included in the final analysis
Key Trial Info
Start Date :
May 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04859725
Start Date
May 31 2021
End Date
June 30 2025
Last Update
January 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000